Skip to Main Content

Andrew Klevorn Quoted in TheStreet on "Pay for Delay" Claims

Firm News | September 9, 2016

Antitrust and Competition partner Andrew Klevorn was quoted in an article in TheStreet regarding recent "pay for delay" accusations involving Mylan and Teva Pharmaceuticals. Andy stated, "Most courts since [the Hatch-Waxman Act] then have looked at these pay for delay claims have concluded that these are illegal. If Mylan did engage in a scheme, they are subject to an investigation." He also noted that the case is contingent upon the attorneys proving that a payment occurred, resulting in a delay of "meaningful competition." ("Did Mylan Purposefully Delay Generic Competition's Entry Into The Market?," September 9, 2016)

Katten Websites   Careers  |  Alumni  |  Mobile Site
Contact Us   Offices  |  Media Center  |  People  |  Email
Legal Notices   Disclaimer  |  Privacy Notice  |  Cookie Notice  |  United Kingdom Notices  | Accessibility 
Attorney Advertisting. © 2019 Katten Muchin Rosenman LLP